H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. Census population 175,265. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Ontario clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Ontario storefront.
361 HCT/P Compliant Tissue Products in Ontario, CA for clinics & physicians. Exclusively 361 HCT/P complia… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of 361 hctp compliant products in Ontario: (1) CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. (2) California Part B wound biologics are reviewed by Noridian Healthcare Solutions under JE, shared with HI, NV. We help with the second file. We do not pretend to be a Ontario storefront.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)17% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 175,265 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 12% of adults in Ontario have diagnosed diabetes — about even with the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the 361 hctp compliant products account.
CDC PLACES (2023, crude prevalence) estimates 12% of adults — about even with the U.S. 12% figure. Obesity is 33.6%; arthritis is 19.6%. That is place-level BRFSS modeling, not a clinic census and not a Ontario trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
California is JE. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
No. Hematogel is a PRP-based wound gel pathway with its own application and documentation. Skin substitutes/CTPs follow Noridian Healthcare Solutions CTP articles. Mixing those codes is a billing error.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12% diabetes and 19.6% arthritis for Ontario — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Ontario, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Ontario is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Ontario — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Ontario. Useful for joint-program math; still needs a diagnosis and privileging.
No Ontario storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.